logo
What to know about paper towel theory

What to know about paper towel theory

The paper towel theory is an analogy in which removing one sheet per day from a roll of paper towels symbolizes fat loss. It illustrates that although progress may be slow and difficult to notice initially, it can become more evident as time goes on.The paper towel theory, also known as the paper towel effect, is an analogy that appears on several websites and blogs dedicated to health, weight loss, or bodybuilding. Social media users have also shared the theory across various platforms.This article examines paper towel theory in more detail, how the body responds to weight loss, tips for safe weight loss, and when to speak with a doctor.What is the paper towel theory?The paper towel analogy may have emerged around 2007, when people began sharing it across weight loss, bodybuilding, and fitness sites.The theory compares losing fat to tearing a single sheet from a paper towel roll each day. At the end of the first week, there may not be a perceptible difference between that roll and a full roll of paper towels. At the end of the second or third week, a person still may not notice much difference between the full roll and the one they have been tearing sheets from every day.After about 6 weeks of removing a sheet a day, however, the difference between the two rolls of paper towels becomes much more evident. Within 12 weeks, the roll with fewer sheets appears significantly smaller than the full roll.The paper towel effect illustrates that consistent fat loss efforts can take time to yield visible results. It also symbolizes how fat loss may be more visible on smaller bodies than larger ones, as the fat covers a smaller surface area.»Learn more:Weight loss vs. fat loss: Differences explainedWhat happens in the body during weight loss?Several changes may occur in the body that can result in weight loss. These include the following:Fat lossThe body stores a type of fat, called triglycerides, inside fat cells, or adipocytes. Most of these fat cells are under the skin.Fat loss occurs when the body transports triglycerides to different parts of the body through the bloodstream to break down and use as energy. The adipocytes remain in place under the skin, but empty out and become smaller as they lose their fat stores. Muscle mass lossA person may lose muscle mass as well as fat when they lose weight.Eating too few calories can decrease the mass of various bodily tissues. Without adequate fat stores to draw from, the body may begin to break down muscles, connective tissues, and organs to use as energy.Losing muscle mass could affect a person's strength, physical function, and metabolism. Scientists recommend that people avoid following very low calorie diets unless a healthcare professional is monitoring the process. Water lossWater accounts for about 50% to 70% of a person's body weight.If a problem occurs in one of the bodily systems responsible for maintaining healthy fluid levels, fluid retention or edema may occur. According to the United Kingdom's National Health Service (NHS), fluid may build up in different parts of the body, which can cause weight gain, swelling, and other symptoms.Treatments like diuretic medication can help remove fluid from the body, which can result in weight loss. However, losing too much water can lead to health complications, including dehydration and kidney damage.Tips for losing weight safelyDoing the following may help a person lose weight safely:eating a balanced and nutrient-rich dietlimiting foods that are high in certain fats and sugardoing at least 150 minutes of moderate intensity exercise per weektracking weight loss and health goalsreducing stress levelsmaintaining a healthy sleep routineseeking support from friends and family setting realistic weight loss goals, such as losing 0.4 to 0.9 kilograms (kg), which is about 1 to 2 pounds (lb), per weekWhen to speak with a doctorIf an individual feels they need help managing their weight or their relationship with food and their body, they may want to speak with a healthcare professional.A healthcare professional may treat overweight and obesity in the following ways:helping a person make certain lifestyle changesreferring a person to a weight management specialistprescribing weight loss medicationperforming weight loss surgeryA healthcare professional may also be able to help if a person has an eating disorder that affects their relationship with food and their mental health, such as binge eating disorder. Treatment may involve:psychotherapymedicationsnutrition counselingSummaryThe paper towel theory is an analogy in which removing one sheet from a paper towel roll each day symbolizes consistent weight loss. It illustrates that fat loss may be imperceptible at first, but the results become more visible over time.Steps a person can take to achieve safe, consistent weight loss include eating a balanced diet, getting regular physical activity, and seeking support from loved ones.If an individual feels that they need help managing their weight or their relationship to food, they may want to consult a healthcare professional for further advice or treatment.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Weight loss pill shows promise in new trial
Weight loss pill shows promise in new trial

The Independent

time43 minutes ago

  • The Independent

Weight loss pill shows promise in new trial

A new weight loss medication, which can be offered by injection or tablet, can help patients lose a significant amount weight, studies suggest. An early study have found that people who received higher doses of amycretin as a weekly jab lost 24.3% of their body weight after 36 weeks of treatment. And initial trials assessing a tablet form of the drug also showed promising results, with patients taking daily tablets losing an average of 13.1% of their body weight after 12 weeks. Weight loss jabs have been hailed as transformative by NHS leaders. But injections come with additional work for over-stretched health services so tablet forms of medication may offer a new hope for the millions of people looking to lose weight. It has been estimated that around 1.5 million Britons are having weight loss jabs, which have been either prescribed through specialist weight loss services or private prescriptions. GPs will be able to dish out that jabs from next week. Amycretin, made by Novo Nordisk, helps to control blood sugar and appetite by targeting two specific receptors in the body – GLP-1 and the amylin receptor. An early trial in 125 adults testing weekly injections of amycretin, which has been published in The Lancet, found that those taking the highest dosage (60mg) lost 24.3% after 36 weeks of treatment. It also showed signs in improving blood sugar levels. Side effects included nausea and vomiting and were mostly mild to moderate and resolved by the end of treatment. 'These phase 1b/2a data support the potential of once-weekly subcutaneous amycretin as a therapeutic for people living with overweight or obesity,' the authors wrote. 'Amycretin appeared safe and tolerable, and there were significant reductions in body weight after 36 weeks of treatment.' The second early trial, published in the same journal, assessed amycretin in tablet form in 144 people over 12 weeks. There were mild to moderate side effects including loss of appetite, nausea and vomiting. Researchers found that people taking the highest dose of 100mg per day, lost 13.1% of their body weight over four months. The authors wrote: 'Amycretin effectively lowered body weight and improved metabolic and glycaemic parameters in people with overweight or obesity. 'Longer studies with more participants are warranted for evaluation of the safety and efficacy of amycretin in individuals living with obesity and type 2 diabetes, and to optimise the dosing regimen.' The studies were also presented at the American Diabetes Association's Scientific Sessions in Chicago, in the US. It comes as a separate study, which was published at the same meeting, examined the effects of weight loss jab Wegovy at higher doses. Researchers found that giving patients 7.2mg of Wegovy, also known as semaglutide, once a week led to an average weight loss of 20.7%, with a third of participants losing 25% or more of their body weight after 72 weeks.

My brother died at 33 — what I wish I'd known
My brother died at 33 — what I wish I'd known

Times

time2 hours ago

  • Times

My brother died at 33 — what I wish I'd known

I remember seeing the troubling spark of recognition in the psychologist's eyes when I told her that my late brother, Charlie, had schizophrenia. We were sitting in her office going through a never-ending pile of forms as part of my seven-year-old son Eddie's autism-assessment process, including my family history. 'Did you know,' she asked, 'that autism used to be known as childhood schizophrenia?' I remember the grating rough texture of the chair I was sitting on prickling against the back of my legs and feeling the inside of my stomach flip. We lost my big brother, Charlie, in 2004 when he was 33 and he hadn't had a particularly happy life. He had been diagnosed with schizophrenia at the age of 18 after a period of psychosis — he had been hearing voices and became convinced that a group of people were out to get him.

Novo Nordisk's experimental drug results in up to 24% weight loss
Novo Nordisk's experimental drug results in up to 24% weight loss

Reuters

time2 hours ago

  • Reuters

Novo Nordisk's experimental drug results in up to 24% weight loss

June 20 (Reuters) - Novo Nordisk ( opens new tab on Friday said full results from early-stage trials show that its experimental drug, amycretin, helped overweight and obese adults lose up to 24% of their weight as the Danish company readies for late-stage studies, opens new tab to start next year. The company said side effects of the drug, tested as both a weekly injection and a daily pill, were mostly gastrointestinal with rates similar to other recent weight loss drugs. The full trial results were presented at the annual meeting of the American Diabetes Association in Chicago and published in the Lancet medical journal. Novo's head of development Martin Holst Lange said the Phase 3 amycretin program starting in 2026 will run "for a couple of years" after which the regulatory review process could start. The company earlier this month said it planned to start late-stage trials of the drug in the first quarter of 2026 after previously announcing the early-stage trial results. Amycretin has a dual-mode action. Like Novo's popular weight-loss drug Wegovy, it mimics the gut hormone GLP-1, but also targets receptors for a hunger-suppressing pancreatic hormone called amylin. Trial results showed that 20-milligram weekly injections of the drug helped overweight or obese patients without diabetes lose 22% of their weight over 36 weeks, with a 60-mg dose resulting in 24.3% weight loss. In the Phase 1 study of once-daily oral amycretin, patients received increasing doses, ranging from 3 mg to a final dose of 100 mg. Patients who took 50 mg of amycretin at the end of the 12-week trial reduced body weight by 10.4% on average, while those taking the maximum dose lost 13.1% of their weight, the company said. Novo said the weight loss did not plateau, suggesting that longer treatment could lead to greater weight loss. In a Lancet commentary, researchers not involved in the amycretin studies said that "while additional weight loss is welcome and helpful, our evolving concept of obesity management has now shifted towards an emphasis on the reduction of the risks and burdens of cardiovascular disease and other comorbidities." Commentators Tricia Tan, professor of metabolic medicine and endocrinology at Imperial College London, and endocrinologist Dr. Bernard Khoo, said studies directly comparing GLP-1 drugs like Novo's Ozempic to drugs like amycretin will be needed to definitively establish their added value and place in obesity management.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store